Articles related to Radiation Oncology

National Cancer Database data suggest that approximately half of prostate cancer focal therapy use from 2010 to 2023 occurred outside current guideline-supported settings, highlighting persistent gaps between clinical practice and available evidence.

The death of a 26-year-old woman diagnosed with metastatic cholangiocarcinoma at age 23 highlights challenges surrounding cancer recognition in younger adults, patient engagement through social media, and communication when treatment options become limited.

Recent compensation surveys place average U.S. oncologist earnings between approximately $360,000 and $465,000 annually, with variation driven by subspecialty, geography, experience level, and persistent demographic pay disparities.

Radiation oncology practices report substantial revenue declines following 2026 CMS coding changes, with some centers citing reimbursement reductions of 15% to 30%. Stakeholders warn the financial pressures could affect treatment access, particularly in community and rural settings.

Artificial intelligence tools are increasingly being integrated into prostate cancer imaging, pathology, prognostication, and treatment planning. Although several platforms have demonstrated promising accuracy and workflow benefits, broad clinical adoption will require prospective validation, regulatory oversight, and careful implementation.

Researchers identified a metabolic pathway in which amino acid breakdown generates propionyl-CoA, sustaining cholesterol production and androgen signaling in prostate cancer models. The findings suggest a potential mechanism of hormone therapy resistance, though clinical relevance remains unproven.